Xylazine

CAS 7361-61-7 4 current records 2 historicalSmall Molecule

Who holds supplier records for Xylazine? 4 organisations hold a current record for Xylazine: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (2), Latvia (1) and Taiwan (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Xylazine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/xylazine

Reading the evidence

  • 4 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 1 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (4)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Xylazine. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Xylazine sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (4)

Certificates of Suitability on the EDQM register for Xylazine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 5 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
NGL FINE-CHEM LIMITED MumbaiIN
CEP 2025-348 - Rev 00
Xylazine hydrochloride for veterinary use
Jun 2026—
SYN-TECH CHEM. & PHARM. CO., LTD. Tainan CityTW
CEP 2014-215 - Rev 02
Xylazine hydrochloride for veterinary use
Jan 2024—
ALIVIRA ANIMAL HEALTH LIMITED VisakhapatnamIN
R0-CEP 2021-030 - Rev 00
Xylazine hydrochloride for veterinary use, Process-II
May 2023—
Joint Stock Company "Grindeks" RigaLV
R1-CEP 2009-081 - Rev 00
Xylazine hydrochloride for veterinary use
Jun 2015—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (2)

Organisations whose Type II DMFs for Xylazine are no longer active. These show a past filing, not current supply.

Show all 2 historical records
  • SELOC FRANCE
    Inactive DMF 7275 · filed Jan 1988
  • PHARM ECO LABORATORIES INC
    Inactive DMF 6849 · filed Feb 1987

Overview

Xylazine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL297362).

Chemical identity

IUPAC name
N-(2,6-dimethylphenyl)-5,6-dihydro-4H-1,3-thiazin-2-amine
Canonical SMILES
CC1=C(C(=CC=C1)C)NC2=NCCCS2
InChIKey
BPICBUSOMSTKRF-UHFFFAOYSA-N
Synonyms
Chanazine, NSC-758142, Xilazina, Xylazine, Xylazine component of tranq, Xylazinum, Xylazin, BAY 1470, WH 7286, CHEBI:92386, Xylaxine, RefChem:56228

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Xylazine?

4 organisations hold an active US FDA Type II Drug Master File or a CEP for Xylazine: Alivira Animal Health Limited (India), Grindeks (Latvia), Ngl Fine Chem Limited (India) and SYN-TECH CHEM AND PHARM CO LTD (Taiwan). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

What do the historical Xylazine records mean?

2 organisations have only inactive Type II DMFs for Xylazine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Xylazine have a European Certificate of Suitability?

Yes. 4 organisations hold a valid CEP for Xylazine on the EDQM register, including NGL FINE-CHEM LIMITED Mumbai (IN), SYN-TECH CHEM. & PHARM. CO., LTD. Tainan City (TW), ALIVIRA ANIMAL HEALTH LIMITED Visakhapatnam (IN) and Joint Stock Company "Grindeks" Riga (LV). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Xylazine supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Xylazine?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.